Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
2.920
+0.120 (4.29%)
At close: Sep 29, 2025, 4:00 PM EDT
2.920
0.00 (0.00%)
After-hours: Sep 29, 2025, 5:18 PM EDT
Health Catalyst Stock Forecast
Stock Price Forecast
The 10 analysts that cover Health Catalyst stock have a consensus rating of "Hold" and an average price target of $4.70, which forecasts a 60.96% increase in the stock price over the next year. The lowest target is $3.50 and the highest is $6.00.
Price Target: $4.70 (+60.96%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 29, 2025.
Analyst Ratings
The average analyst rating for Health Catalyst stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 5 | 5 | 5 | 5 | 3 | 2 |
| Hold | 4 | 4 | 4 | 4 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +71.23% | Aug 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +36.99% | Aug 28, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $8 → $4 | Buy → Hold | Downgrades | $8 → $4 | +36.99% | Aug 27, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +105.48% | Aug 11, 2025 |
Financial Forecast
Revenue This Year
320.44M
from 306.58M
Increased by 4.52%
Revenue Next Year
322.27M
from 320.44M
Increased by 0.57%
EPS This Year
0.22
from -1.15
EPS Next Year
0.44
from 0.22
Increased by 95.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 351.8M | 381.9M | ||
| Avg | 320.4M | 322.3M | ||
| Low | 303.4M | 292.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 14.7% | 19.2% | ||
| Avg | 4.5% | 0.6% | ||
| Low | -1.1% | -8.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.30 | 0.69 | ||
| Avg | 0.22 | 0.44 | ||
| Low | 0.16 | 0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 208.8% | ||
| Avg | - | 95.1% | ||
| Low | - | 22.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.